- Trials with a EudraCT protocol (25)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
25 result(s) found for: Biochemical Assays.
Displaying page 1 of 2.
EudraCT Number: 2011-004831-30 | Sponsor Protocol Number: UC-0101/1104 | Start Date*: 2012-09-21 | |||||||||||
Sponsor Name:UNICANCER | |||||||||||||
Full Title: Safety and efficacy of radiotherapy combined with a 6-month LH-RH agonist and abiraterone hormone therapy treatment in biochemically-relapsing prostate cancer following surgery. | |||||||||||||
Medical condition: Biochemically-relapsing prostate adenocarcinoma following radical prostatectomy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000155-21 | Sponsor Protocol Number: UC-0160/1702 | Start Date*: 2019-06-04 | |||||||||||
Sponsor Name:UNICANCER | |||||||||||||
Full Title: An open label, randomized, phase III study, evaluating the efficacy of a Combination of Apalutamide with Radiotherapy and LHRH Agonist in high-risk postprostatectomy biochemically relapsed prostate... | |||||||||||||
Medical condition: High-risk biochemically-relapsed prostate adenocarcinoma following radical prostatectomy. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001252-35 | Sponsor Protocol Number: DANA-2018-1. | Start Date*: 2018-09-06 |
Sponsor Name:Kirsten Møller | ||
Full Title: Neuroplasticity induced by general anaesthesia | ||
Medical condition: This trial investigates the effects of general anaesthesia on the helathy human brain. Thus, only healthy, young adults with no medical conditions will participate as volunteers in this study. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DK (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004049-29 | Sponsor Protocol Number: ISSBRIL0264 | Start Date*: 2015-03-10 |
Sponsor Name:University of Leicester | ||
Full Title: Investigating Aspirin and Ticagrelor for the prevention of tumour cell-induced platelet aggregation | ||
Medical condition: Solid cancer metastasis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-002686-30 | Sponsor Protocol Number: CEP-AZ-SH-02 | Start Date*: 2009-04-15 | |||||||||||
Sponsor Name:Christie Hospital NHS Foundation Trust | |||||||||||||
Full Title: Assessment of the effects of the specific endothelin-A antagonist ZD4054 on prostate cancer biomarkers in patients with castrate-resistant metastatic disease | |||||||||||||
Medical condition: Prostate cancer | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001421-41 | Sponsor Protocol Number: TWOProtocolv1.0 | Start Date*: 2018-05-22 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: The TWO Study: Transplantation Without Over-immunosuppression. A Phase IIb Trial of Regulatory T Cells in Renal Transplantation. | |||||||||||||
Medical condition: Renal (allograft) transplant | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-003915-11 | Sponsor Protocol Number: CarniValI (Uni-Koeln-1107) | Start Date*: 2009-09-24 | |||||||||||
Sponsor Name:University of Utah | |||||||||||||
Full Title: Phase I/II Trial of Valproic Acid and Carnitine in Infants with Spinal Muscular Atrophy Type I (CARNI-VAL Type I) | |||||||||||||
Medical condition: Spinal Muscular Atrophy Type I in infants | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000462-62 | Sponsor Protocol Number: Statex1 | Start Date*: 2015-09-23 |
Sponsor Name:Radboud university medical centre | ||
Full Title: The effects of statins on skeletal muscle mitochondria: is exercise the medicine? | ||
Medical condition: Asymp and symp statin users will undergo baseline measurements of skeletal muscle mitochondrial function and muscle function after which they will be switched to a single-blind placebo intervention... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-002225-30 | Sponsor Protocol Number: 69HCL18_0957 | Start Date*: 2019-07-18 | ||||||||||||||||
Sponsor Name:Hospices Civils de Lyon | ||||||||||||||||||
Full Title: Impact of low protein diet supplemented with ketoanalogues on uremic toxins production and glucose metabolism in chronic kidney disease_KETO GUT study | ||||||||||||||||||
Medical condition: chronic kidney disease | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: FR (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004882-15 | Sponsor Protocol Number: STOP-NUC | Start Date*: 2014-10-30 | |||||||||||
Sponsor Name:Universität Leipzig | |||||||||||||
Full Title: A multicentre randomized controlled trial evaluating the rate of sustained remission and the safety when stopping nucleos(t)ide analogue treatment in non-cirrhotic HBeAg-negative chronic Hepatitis ... | |||||||||||||
Medical condition: HBeAg negative chronic Hepatitis B virus (HBV) infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003896-20 | Sponsor Protocol Number: 3667 | Start Date*: 2013-02-14 |
Sponsor Name:The Royal Marsden NHS Foundation Trust [...] | ||
Full Title: TAX-TORC: A Phase I multi-centre trial of the combination of AZD2014 (dual TORC1 and TORC2 inhibitor) and weekly paclitaxel in patients with solid tumours | ||
Medical condition: Solid tumours | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002837-48 | Sponsor Protocol Number: HEAL-1-v1.5 | Start Date*: 2017-12-22 |
Sponsor Name:Erasmus MC | ||
Full Title: HIV Eradication by combining Agents to reverse Latency in vivo (HEAL-1): a randomized controlled trial. | ||
Medical condition: Adults with human immunodeficiency virus type-1 infection on antiretroviral treatment with adequate viral suppression and good cellular immunity. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002348-27 | Sponsor Protocol Number: PH2/052 | Start Date*: 2007-10-26 |
Sponsor Name:Cancer Research UK | ||
Full Title: A Cancer Research UK Phase II Proof of Principle Trial of the activity of the PARP-1 inhibitor, AG-014699, in known carriers of a BRCA 1 or BRCA 2 mutation with locally advanced or metastatic breas... | ||
Medical condition: advanced or metastatic breast or ovarian carcinoma (proven carrier of a mutation in BRCA1 or 2 gene) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-004011-44 | Sponsor Protocol Number: UofATURRIFIC | Start Date*: 2020-05-20 |
Sponsor Name:The University of Adelaide | ||
Full Title: A randomised trial of URsodeoxycholic acid versus RIFampicin in severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC study, comparing their effectiveness in the reduction of pruri... | ||
Medical condition: Intrahepatic Cholestasis of Pregnancy (ICP) is an serious liver condition in pregnancy. The main symptom of this is itching. Ursodeoxycholic acid is routinely used to treat cholestasis but is not... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Ongoing) GB (GB - no longer in EU/EEA) SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004824-77 | Sponsor Protocol Number: 27UCS2015 | Start Date*: 2016-06-23 | |||||||||||
Sponsor Name:ENTE OSPEDALIERO OSPEDALI GALLIERA | |||||||||||||
Full Title: A randomized, phase II, double-blind, placebo-controlled, multicenter, 2x2 factorial design biomarker tertiary prevention trial of low-dose aspirin and metformin in resected stage I-III colorectal ... | |||||||||||||
Medical condition: Surgical resected colorectal cancer (stage I-III) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001135-12 | Sponsor Protocol Number: 204812 | Start Date*: 2016-10-27 | |||||||||||
Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
Full Title: A Phase II, randomised, observer-blind, controlled, multi-country study to rank different formulations of GSK Biologicals’ investigational RSV vaccine (GSK3003891A), based on immunogenicity, reacto... | |||||||||||||
Medical condition: Respiratory Syncytial Virus | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DE (Completed) EE (Completed) BE (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003405-98 | Sponsor Protocol Number: dexFEMv2 | Start Date*: 2012-12-03 | |||||||||||
Sponsor Name:ACCORD University of Edinburgh [...] | |||||||||||||
Full Title: Developmental Clinical Studies - Reversing endometrial glucocorticoid deficiency in heavy menstrual bleeding | |||||||||||||
Medical condition: Endometrial glucocorticoid deficiency in Heavy Menstrual Bleeding | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002690-35 | Sponsor Protocol Number: OEV123 | Start Date*: 2017-05-08 | ||||||||||||||||
Sponsor Name:Scandinavian Biopharma AB | ||||||||||||||||||
Full Title: A randomized, placebo-controlled phase IIb (OEV 123) study to evaluate safety, immunogenicity, diagnostic methodology, and estimate vaccine efficacy of an oral enterotoxigenic Escherichia coli (ET... | ||||||||||||||||||
Medical condition: Healthy voluteers (prevention of diarrheal disease due to infection with enterotoxigenic E. coli [ETEC]) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: FI (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-003599-39 | Sponsor Protocol Number: SAKK08/15 | Start Date*: 2017-12-13 |
Sponsor Name:Swiss Group for Clinical Cancer Research (SAKK) | ||
Full Title: PROMET - Multicenter, Randomized Phase II Trial of Salvage Radiotherapy +/- Metformin for Patients with Prostate Cancer after Prostatectomy | ||
Medical condition: Histologically confirmed adenocarcinoma of the prostate without small cell features with PSA progression after radical prostatectomy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: DE (Completed) FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-000616-28 | Sponsor Protocol Number: OCTO_038 | Start Date*: 2013-08-22 | |||||||||||
Sponsor Name:University of Oxford | |||||||||||||
Full Title: Phase II trial of Linsitinib (anti-IGFR/IR) in patients with relapsed and/or refractory Ewing Sarcoma | |||||||||||||
Medical condition: Relapsed and/or refractory Ewing sarcoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) IT (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.